Read More

Atara Biotherapeutics To Receive Additional Near-Term Milestone Payment Under Updated Tabelecleucel Commercialization Agreement With Pierre Fabre; Atara To Receive Additional $30M Upon European Commission Approval And Filing Of Tab-Cel

Atara to Receive Additional USD 30 Million Upon European Commission (EC) Approval and Filing of Tab-cel® Marketing Authorization Transfer to Pierre Fabre Responses Submitted to European Medicines

ATRA